Acme United (ACU) Sidoti Micro-Cap Virtual Conference summary
Event summary combining transcript, slides, and related documents.
Sidoti Micro-Cap Virtual Conference summary
20 May, 2026Business overview and segment performance
Operates in two main segments: cutting solutions (Westcott brand, global leader, 70 million scissors/year) and first aid/safety (larger, high recurring revenue from refills, 8%-10% organic growth).
Cutting segment is mature, slow-growing, but generates strong cash flow and holds leading market shares across diverse applications.
First aid and safety segment benefits from regulatory drivers, high margins, and a broadening product portfolio, including bleed control and arrhythmia solutions.
Recent emphasis on expanding first aid/safety due to its broader market, life-saving impact, and annuity-like revenue stream.
Acquisitions in first aid focus on vertical integration and expanding product offerings, such as the My Medic acquisition.
Growth strategy and recent initiatives
Organic growth historically 6%-7%, with first aid outpacing cutting; tariffs impacted retail last year, but first aid remained strong.
My Medic acquisition adds $19 million in sales, strong D2C presence, and 500,000 social media followers, enhancing direct consumer engagement and training.
Integration of My Medic focuses on leveraging existing distribution, expanding Amazon presence, and achieving cost efficiencies through sourcing and vertical integration.
Cutting segment expects growth in Q2 and Q3, driven by new customers (e.g., dollar stores), expanded craft product lines, and increased retail promotions.
International expansion is a priority for first aid, with significant growth in Europe and Canada, and a new facility opening near Montreal.
Financials, margins, and capital allocation
EBITDA ranges from $20M-$25M, funding acquisitions, dividends (~$2M/year), and facility investments.
CapEx is $6M-$7M annually, with $1M for maintenance and the rest for automation and productivity improvements across nine North American plants.
Gross margins run 39%-40%, with first aid slightly higher than cutting; My Medic has higher gross margins but also higher SG&A due to D2C marketing.
About 20% of revenue is international, with ongoing efforts to increase this share.
Targeting $225M-$230M in revenue this year, aiming for $300M within three years through 8%-10% annual growth and further acquisitions in first aid.
Latest events from Acme United
- Innovation and acquisitions fuel robust growth in sales, earnings, and market expansion.ACU
Investor presentation20 May 2026 - Q1 2026 sales up 14%, but net income down 40% as higher costs and tariffs offset gains.ACU
Q1 20266 May 2026 - All proposals, including board elections and stock plan amendments, were approved by majority vote.ACU
AGM 202628 Apr 2026 - Shareholders will vote on director elections, stock option plan expansion, executive pay, and auditor ratification.ACU
Proxy filing27 Mar 2026 - Record 2025 results and Q4 growth, with acquisitions and investments fueling future expansion.ACU
Q4 202527 Feb 2026 - Q2 net income up 29% with margin gains and Elite First Aid acquisition completed.ACU
Q2 20243 Feb 2026 - Q3 net sales fell 4% but net income rose 3% as Europe and product lines outperformed.ACU
Q3 202419 Jan 2026 - Record sales, product innovation, and supply chain shifts drive growth and margin expansion.ACU
17th Annual LD Micro Main Event Conference18 Jan 2026 - Revenue growth, innovation, and acquisitions position the firm for $300M in sales by 2027.ACU
2024 Southwest IDEAS Conference12 Jan 2026